Roger Jeffs Liquidia Corp (LQDA) insider trading activity

Roger Jeffs is Chief Executive Officer of Liquidia Corp. Currently has a direct ownership of 1.04 Million shares of LQDA, which is worth approximately $20 Million. The most recent transaction as insider was on Jul 14, 2025, when has been sold 20,252 shares (Common Stock) at a price of $14.28 per share, resulting in proceeds of $289,198. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.04M

3.19% 3M change

26.82% 12M change

Total Value Held $20 Million

ROGER JEFFS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 14 2025	SELL Open market or private sale	$289,198 $14.28 p/Share	20,252 Reduced 1.91%	1,038,560 Common Stock
Jul 14 2025	SELL Open market or private sale	$289,198 $14.28 p/Share	20,252 Reduced 1.91%	1,038,560 Common Stock
Jul 11 2025	BUY Exercise of conversion of derivative security	-	13,833 Added 1.29%	1,058,812 Common Stock
Jul 11 2025	BUY Exercise of conversion of derivative security	-	13,833 Added 1.29%	1,058,812 Common Stock
Jun 04 2025	SELL Open market or private sale	$519,451 $16.97 p/Share	30,610 Reduced 2.85%	1,044,979 Common Stock
Jun 03 2025	BUY Exercise of conversion of derivative security	-	69,169 Added 6.04%	1,075,589 Common Stock
Apr 14 2025	SELL Open market or private sale	$191,744 $13.57 p/Share	14,130 Reduced 1.38%	1,006,420 Common Stock
Jan 14 2025	SELL Open market or private sale	$263,200 $11.78 p/Share	22,343 Reduced 2.15%	1,019,177 Common Stock
Jan 11 2025	BUY Grant, award, or other acquisition	-	229,327 Added 18.05%	1,041,520 Common Stock
Oct 14 2024	SELL Open market or private sale	$89,468 $11.11 p/Share	8,053 Reduced 0.98%	812,193 Common Stock
Jul 12 2024	SELL Open market or private sale	$100,904 $12.53 p/Share	8,053 Reduced 0.97%	818,932 Common Stock
Apr 12 2024	SELL Open market or private sale	$121,888 $14.58 p/Share	8,360 Reduced 1.0%	826,985 Common Stock
Mar 18 2024	SELL Open market or private sale	$452,183 $15.82 p/Share	28,583 Reduced 3.31%	835,345 Common Stock
Jan 11 2024	BUY Grant, award, or other acquisition	-	221,338 Added 20.43%	862,143 Common Stock
Dec 14 2023	BUY Open market or private purchase	$1,000,001 $7.16 p/Share	139,665 Added 17.89%	640,805 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	289,500 Added 36.82%	496,749 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	-	15,807 Added 7.09%	207,249 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	-	47,423 Added 18.62%	207,250 Common Stock
Sep 06 2022	BUY Open market or private purchase	$244,077 $5.57 p/Share	43,820 Added 21.52%	159,827 Common Stock
Aug 31 2022	BUY Open market or private purchase	$4,866 $4.9 p/Share	993 Added 0.85%	116,007 Common Stock
Apr 13 2021	BUY Open market or private purchase	$249,999 $2.52 p/Share	99,206 Added 47.04%	111,706 Common Stock

Also insider at

AXSM

Axsome Therapeutics, Inc. Healthcare

ALBO

ALBIREO PHARMA, INC. Healthcare

Director

Roger Jeffs

Chief Executive Officer

Morrisville, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LQDA shares.

Notify only if

Value

Insider Trading

Get notified when an Liquidia Corp insider buys or sells LQDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Liquidia Corp

Track Activities on LQDA

Account